The DNA damage response and inflammation in cancer

V Klapp, B Álvarez-Abril, G Leuzzi, G Kroemer, A Ciccia… - Cancer discovery, 2023 - AACR
Genomic stability in normal cells is crucial to avoid oncogenesis. Accordingly, multiple
components of the DNA damage response (DDR) operate as bona fide tumor suppressor …

Tissue multiplex analyte detection in anatomic pathology–pathways to clinical implementation

KA Wharton Jr, D Wood, M Manesse… - Frontiers in molecular …, 2021 - frontiersin.org
Background: Multiplex tissue analysis has revolutionized our understanding of the tumor
microenvironment (TME) with implications for biomarker development and diagnostic …

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade

C Dmello, J Zhao, L Chen, A Gould, B Castro… - Nature …, 2023 - nature.com
Whereas the contribution of tumor microenvironment to the profound immune suppression of
glioblastoma (GBM) is clear, tumor-cell intrinsic mechanisms that regulate resistance to CD8 …

A phase I/II trial of oral SRA737 (a Chk1 Inhibitor) given in combination with low-dose gemcitabine in patients with advanced cancer

R Jones, R Plummer, V Moreno, L Carter, D Roda… - Clinical Cancer …, 2023 - AACR
Abstract Purpose: This was a Phase I/II trial of the novel checkpoint kinase 1 (Chk1) inhibitor
SRA737 given in combination with gemcitabine. Its objectives were to establish the safety …

A novel oncogene trigger transposable element derived‐1 promotes oral squamous cell carcinoma progression via evoking immune inhibition

X Qiao, L Zhu, R Song, C Shang… - Molecular …, 2023 - Wiley Online Library
Oral squamous cell carcinoma (OSCC) is one of the most common head and neck
squamous cell carcinomas (HNSCC) globally. Its incidence rate is rapidly increasing, and its …

Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival

T Xie, KA Dickson, C Yee, Y Ma, CE Ford, NA Bowden… - Cancers, 2022 - mdpi.com
Simple Summary Synthetic lethality approaches to cancer therapy involves combining
events to cause cancer cell death. Using this strategy, major advances have occurred in the …

[HTML][HTML] Targeted treatment of head and neck (pre) cancer: preclinical target identification and development of novel therapeutic applications

AM van Harten, RH Brakenhoff - Cancers, 2021 - mdpi.com
Head and neck squamous cell carcinomas (HNSCC) develop in the mucosal lining of the
upper-aerodigestive tract. In carcinogen-induced HNSCC, tumors emerge from …

Egfr inhibition by cetuximab modulates hypoxia and ifn response genes in head and neck squamous cell carcinoma

R Chaudhary, RJC Slebos, LC Noel, F Song… - Cancer Research …, 2023 - AACR
Head and neck squamous cell carcinoma (HNSCC) has one of the most hypoxic and
immunosuppressive tumor microenvironments (TME) among solid tumors. However, there is …

New horizons for platinum-resistant ovarian cancer: insights from the 2023 American Society of Clinical Oncology (ASCO) and European Society for Medical Oncology …

K El Bairi, A Madariaga, D Trapani… - International Journal of …, 2024 - ijgc.bmj.com
Platinum-resistant ovarian cancer is difficult to treat and has a poor prognosis. Patients with
platinum-resistant ovarian cancer have limited treatment options and often have a limited …

New insights into RAS in head and neck cancer

S Jagadeeshan, OZ Novoplansky, O Cohen… - … et Biophysica Acta (BBA …, 2023 - Elsevier
RAS genes are known to be dysregulated in cancer for several decades, and substantial
effort has been dedicated to develop agents that reduce RAS expression or block RAS …